AndroGel® is the first-ever testosterone replacement gel to be approved by the FDA for replacement therapy in men for conditions associated with low testosterone. Low testosterone, also known as hypogonadism, affects approximately four to five million American men.

The condition is linked with diminished interest in sex, impotence, reduced lean body mass, decreased bone density and lowered mood and energy levels. AndroGel® is available with a prescription in pharmacies throughout the United States from the mid-summer 2000 by Unimed Pharmaceuticals.

The unique method of transport (rub in gel) offers many benefits. Those traumatized by needles will surely enjoy rubbing in testosterone to the skin, apposed to injecting it intra-muscularly. Although the therapeutic dose may fall short of being anabolic enough for some.